Background: While EEG is frequently reported as abnormal after chimeric antigen receptor (CAR) T-cell therapy, its clinical significance remains unclear. We aim to systematically describe EEG features in a large single-center cohort and correlate them with clinical and radiological findings. Methods: We retrospectively identified patients undergoing CAR T-cell therapy who had continuous EEG. Neurotoxicity grades, detailed neurological symptoms, and brain MRI or FDG-PET were obtained. Correlation between clinical and radiological findings and EEG features was assessed. Results: In 81 patients with median neurotoxicity grade 3 (IQR 2-3), diffuse EEG background slowing was the most common finding and correlated with neurotoxicity severity (P
CITATION STYLE
Beuchat, I., Danish, H. H., Rubin, D. B., Jacobson, C., Robertson, M., Vaitkevicius, H., & Lee, J. W. (2022). EEG findings in CAR T-cell-associated neurotoxicity: Clinical and radiological correlations. Neuro-Oncology, 24(2), 313–325. https://doi.org/10.1093/neuonc/noab174
Mendeley helps you to discover research relevant for your work.